I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q2 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,094 | -50.4% | 84,162 | +12.3% | 0.00% | – |
| Q2 2023 | $224,062 | -25.6% | 74,937 | -13.9% | 0.00% | – |
| Q1 2023 | $301,096 | -3.9% | 87,022 | +16.1% | 0.00% | – |
| Q4 2022 | $313,270 | +4.4% | 74,945 | +0.2% | 0.00% | – |
| Q3 2022 | $300,000 | -64.5% | 74,828 | -0.0% | 0.00% | – |
| Q2 2022 | $846,000 | -23.0% | 74,830 | +10.7% | 0.00% | – |
| Q1 2022 | $1,098,000 | -44.5% | 67,611 | +61.8% | 0.00% | – |
| Q4 2021 | $1,980,000 | -22.9% | 41,782 | +17.9% | 0.00% | -100.0% |
| Q3 2021 | $2,569,000 | +27.7% | 35,440 | +48.0% | 0.00% | – |
| Q2 2021 | $2,011,000 | +159.8% | 23,954 | +50.0% | 0.00% | – |
| Q1 2021 | $774,000 | +20.7% | 15,973 | +17.5% | 0.00% | – |
| Q4 2020 | $641,000 | +88.5% | 13,597 | +88.0% | 0.00% | – |
| Q3 2020 | $340,000 | +58.1% | 7,232 | +0.8% | 0.00% | – |
| Q2 2020 | $215,000 | – | 7,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
| Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
| IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
| Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
| EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
| HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
| Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
| Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |